Variant report
Variant | nsv875791 |
---|---|
Chromosome Location | chr2:212824999-212874828 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:255)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:212819022..212821702-chr2:212822393..212825012,4 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ERBB4 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573805362 | chr2:212825491-212825492 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs542926062 | chr2:212825496-212825497 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs547651696 | chr2:212825512-212825513 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs558272344 | chr2:212826060-212826061 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs141317916 | chr2:212826062-212826063 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs145267038 | chr2:212826176-212826177 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs183661913 | chr2:212826198-212826199 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs75641218 | chr2:212826204-212826205 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs147902674 | chr2:212826208-212826209 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs572692793 | chr2:212826224-212826225 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs368579840 | chr2:212826273-212826274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544851534 | chr2:212826278-212826279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs141598999 | chr2:212826287-212826288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186847205 | chr2:212826335-212826336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs34306926 | chr2:212826392-212826393 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs560693109 | chr2:212826404-212826405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370996306 | chr2:212826438-212826439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs67565187 | chr2:212826472-212826473 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs150431648 | chr2:212826477-212826478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs535225313 | chr2:212826569-212826570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551955918 | chr2:212826614-212826615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571877890 | chr2:212826635-212826636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573559977 | chr2:212826697-212826698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73986004 | chr2:212826706-212826707 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs191680770 | chr2:212826727-212826728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573938311 | chr2:212826824-212826825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542204813 | chr2:212826841-212826842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs28535995 | chr2:212826903-212826904 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs565694624 | chr2:212826908-212826909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371236513 | chr2:212826928-212826929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs143951482 | chr2:212826951-212826952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs72935738 | chr2:212826952-212826953 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs74746441 | chr2:212826982-212826983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs839500 | chr2:212826983-212826984 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs138122499 | chr2:212826990-212826991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546419662 | chr2:212827039-212827040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs374831283 | chr2:212827077-212827078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368702451 | chr2:212827083-212827084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181866109 | chr2:212827095-212827096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368080912 | chr2:212827098-212827099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs372630600 | chr2:212827123-212827124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561071979 | chr2:212827161-212827162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529646100 | chr2:212827214-212827215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540274822 | chr2:212827235-212827236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114203671 | chr2:212827241-212827242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546709625 | chr2:212827254-212827255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs552125953 | chr2:212827255-212827256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs571728337 | chr2:212827258-212827259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs16847346 | chr2:212827279-212827280 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs576476651 | chr2:212827308-212827309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 18990708 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:212826200-212826400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr2:212826400-212827200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr2:212827200-212827600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:212841800-212842600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr2:212845800-212847400 | Enhancers | Fetal Heart | heart |
6 | chr2:212845800-212848200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr2:212845800-212848200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr2:212846400-212846600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr2:212846400-212848000 | Enhancers | HUVEC | blood vessel |
10 | chr2:212847400-212853000 | Weak transcription | Fetal Heart | heart |
11 | chr2:212853000-212853800 | Enhancers | Fetal Heart | heart |
12 | chr2:212854600-212855200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr2:212859400-212859800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
14 | chr2:212859400-212859800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
15 | chr2:212861400-212861800 | Enhancers | GM12878-XiMat | blood |
16 | chr2:212865000-212865200 | Enhancers | Brain Hippocampus Middle | brain |
17 | chr2:212865200-212865800 | Weak transcription | Brain Hippocampus Middle | brain |
18 | chr2:212865800-212866400 | Enhancers | Brain Anterior Caudate | brain |
19 | chr2:212865800-212866600 | Enhancers | Brain Hippocampus Middle | brain |
20 | chr2:212872600-212874400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
21 | chr2:212874200-212874800 | Enhancers | Brain Angular Gyrus | brain |
22 | chr2:212874400-212875800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |